Cheminformatic Tools and Databases for Pharmacology

session 28628 - Total of 1 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
NERATINIB

NERATINIB


ATC L01EH02

ANTINEOPLASTIC
TREATMENT OF ADULT PATIENTS WITH EARLY STAGE HER2-OVEREXPRESSED/AMPLIFIED BREAST CANCER
EGFR KINASE INHIBITOR
HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) AND HER4 INHIBITOR

ORAL

Tmax 5 HOUR

VD 6433 LITER

PPB 99 PERCENT

Cl 281 LITER / HOUR

HT 14.6 HOUR

SOLUBILITY SPARINGLY SOLUBLE AT PH 1.2 (32.90 MG/ML) AND INSOLUBLE AT APPROXIMATE PH 5.0 AND ABOVE (0.08 MG/ML OR LESS)

EGFR
HER2
HER4

Receptor tyrosine-protein kinase erbB-4 UNIPROT Q15303 ERBB4 -- Epidermal growth factor receptor UNIPROT P00533 EGFR

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |